NasdaqCM:SMTI
NasdaqCM:SMTIMedical Equipment

Sanara MedTech (SMTI) Is Down 23.5% After Q3 Loss and THP Exit – Has the Investment Case Shifted?

Sanara MedTech Inc. has reported its third quarter 2025 earnings, revealing sales of US$26.33 million and a net loss of US$30.41 million, and announced the discontinuation of its Tissue Health Plus (THP) operations completed in November 2025 as part of a business realignment toward its core surgical segment. This shift not only repositions the company’s operational focus but also signals a response to deeper losses and the challenges faced by its digital health initiative. Now, we'll explore...
TSX:STGO
TSX:STGOMetals and Mining

TSX Penny Stocks To Watch In November 2025

As November unfolds, the Canadian market reflects a complex interplay of AI enthusiasm and valuation adjustments, with corporate earnings remaining robust despite recent equity market pullbacks. In such a landscape, investors often look towards smaller or newer companies for opportunities that larger firms may not offer. While "penny stocks" might sound like a concept from trading days gone by, they continue to highlight potential in less-established companies; those built on strong...